Form 4: Phathom Pharmaceuticals Director Reports Share Transfer

Phathom Pharmaceuticals Director Asit Parikh reported a transfer of 28,000 common shares to a trust for his spouse's benefit.

Summary

• Asit Parikh, a Director at Phathom Pharmaceuticals, Inc., has reported a transaction involving 28,000 shares of common stock.
• The transaction, dated May 22, 2026, involved the transfer of these shares for no monetary consideration.
• The shares were transferred to a trust established for the benefit of the Reporting Person's spouse.
• Asit Parikh serves as the trustee for this trust.
• Following this transfer, the Reporting Person directly owns 24,122 shares and indirectly owns 148,500 shares through the trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine transfer of shares for estate planning purposes by a director, rather than a transaction indicative of strong conviction or concern about the company's future.

Positives

• The transfer of shares to a spouse's trust can be seen as a form of estate planning or wealth management.
• The reporting person continues to hold a significant number of shares, both directly and indirectly, indicating continued investment in the company.

Negatives

• The transfer of shares, even without consideration, represents a reduction in the reporting person's direct beneficial ownership.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently signal changes in company performance, but rather changes in insider holdings.

Related Party Transactions

• Transfer of 28,000 common shares from Asit Parikh to a trust for the benefit of his spouse, where Asit Parikh serves as trustee.

Stakeholder Impact

• Shareholders: No immediate impact expected, as this is a transfer of existing shares and not a sale into the open market. Indirect ownership by the reporting person remains significant.
• Reporting Person (Asit Parikh): Direct beneficial ownership decreases, while indirect beneficial ownership through the trust increases.
• Spouse of Reporting Person: Benefits from the establishment of the trust holding the shares.

Key Dates

Keywords

Phathom Pharmaceuticals, PHAT, Form 4, SEC Filing, Insider Trading, Share Transfer, Beneficial Ownership, Director, Trust